Pressure BioSciences (Pressure BioSciences) Risk Assessment

View and export this data going back to 1996. Start your Free Trial

What is Pressure BioSciences Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Pressure BioSciences is: High Risk: High uncertainty.

Competitive Comparison of Pressure BioSciences's Risk Assessment

For the Medical Devices subindustry, Pressure BioSciences's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pressure BioSciences's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Pressure BioSciences's Risk Assessment falls into.

Pressure BioSciences (OTCPK:PBIO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Pressure BioSciences Risk Assessment Related Terms

Thank you for viewing the detailed overview of Pressure BioSciences's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pressure BioSciences (Pressure BioSciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pressure BioSciences Inc (OTCPK:PBIO) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

14 Norfolk Avenue, South Easton, MA, USA, 02375

Website

https://www.pressurebiosciences.com

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.

Executives

Daniel Joseph Shea	officer: Senior Vice President & CFO	2 MINUTEMAN ROAD, MEDFIELD MA 02052
Bradford Addison Young	officer: Chief Commercial Officer	513 LITTLE JOHN HILL, ANNAPOLIS MD 21405
Richard T Schumacher	director, officer: Chief Executive Officer	375 WEST STREET, WEST BRIDGEWATER MA 02379
Nathan Lawrence	other: VP Sales and Marketing	321 MANLEY STREET, WEST BRIDGEWATER MA 02379
Richard Thomley	officer: Chief Financial Officer	C/O PRESSURE BIOSCIENCES, INC., 14 NORFOLK AVE., SOUTH EASTON MA 02375
Kevin Pollack	director	150 RAINVILLE ROAD, TARPON SPRINGS FL 34689
Michael S Urdea	director	100 BUNCE MEADOWS DRIVE, ALAMO CA 94507
Alexander V Lazarev	officer: VP of REsearch and Development	18 WINCHESTER DRIVE, LEXINGTON MA 02420
Edmund Y Ting	officer: Senior VP of Engineering	23642 123RD PLACE SOUTHEAST, KENT WA 48031
Vito J Mangiardi	director	12 POINT GALLINAS ROAD, SAN RAFAEL CA 94903
Jeffrey N Peterson	director	1031 SHORELINE DRIVE, SAN MATEO CA 94404
Mir Conrad F	officer: CFO	19 BRIER LANE, CLIFTON NJ 07012
Clayton A Struve	10 percent owner	175 W JACKSON BLVD, SUITE 440, CHICAGO IL 60604
Css Llc/il	other: (a)	175 WEST JACKSON BLVD, SUITE 440, CHICAGO IL 60604
R Wayne Fritzsche	director	835 GREENS PARKWAY, SUITE 150, HOUSTON TX 77067